Blog
Clinical evidence insights, methodology deep-dives, and the latest in clinical decision support from the Ailva team.
Polypharmacy in Elderly Patients: An Evidence-Based Deprescribing Framework
Your 82-year-old patient takes twelve medications. Each one was individually appropriate when prescribed. The problem is not any single drug — it is the cumulative burden of all of them in an aging body. Here is a structured approach to deciding what to stop, and in what order.
Free Clinical Tools Every Physician Should Know About in 2026
The landscape of free clinical tools has expanded significantly. Here is a practical overview of what is available at no cost for point-of-care reference, evidence synthesis, drug interactions, and more.
GLP-1 Receptor Agonists Beyond Diabetes: Cardiovascular and Renal Evidence
SELECT proved semaglutide cuts MACE in patients without diabetes. FLOW stopped early because semaglutide slowed CKD progression that dramatically. Here is what the trials actually show, and what they mean for the patient in your office tomorrow.
How to Verify Medical Citations: A Step-by-Step Guide
A practical, step-by-step guide for physicians to verify whether a medical citation is real, accurate, and correctly attributed — whether it comes from a clinical tool, a colleague, or a published review.
Understanding Preprint Evidence: What Clinicians Need to Know
One-third of practicing physicians have used a preprint to inform a clinical decision. One preprint — dexamethasone in severe COVID — saved thousands of lives by bypassing the publication timeline. Another — hydroxychloroquine — caused widespread harm. The format is neutral. The quality of the science is what matters.
Beyond Traditional Medical References: The Evolution of Clinical Decision Support
From textbooks to UpToDate to search-based tools to clinical intelligence platforms — each generation solved problems the last could not. Here is what changed and why it matters.
Interpreting Elevated hs-CRP in the Context of Multiple Comorbidities
Your 64-year-old patient has an hs-CRP of 8.2 and carries five diagnoses that all cause inflammation. The CRP is elevated. By which condition? All of them? Or something new you have not found yet?
Why Clinical AI Tools Hallucinate Citations — And How to Verify Them
A colleague asked me to check a citation from an AI clinical summary. The paper it referenced — a 2023 Lancet meta-analysis — did not exist. The authors were real. The journal was real. The study was fabricated. This happens 28% of the time.
The Complete Guide to Clinical Decision Support in 2026
A definitive guide to clinical decision support tools in 2026 — covering the history, current landscape, evaluation criteria, citation verification, cross-system reasoning, and future directions of CDS technology for physicians.
Can Physicians Trust Clinical Intelligence Tools? An Evidence-Based Framework
Physician trust in clinical tools should be earned through transparency, verification, and evidence — not marketing. Here is a framework for evaluating whether a clinical intelligence tool deserves your trust.
Clinical Citation Verification: A Comprehensive Guide for Healthcare Professionals
Why clinical citations hallucinate, the types of hallucinations that matter most, and how verification systems work. A comprehensive guide for any healthcare professional relying on evidence-based tools.
Tools for Complex Multi-System Cases: What Physicians Need
Complex multi-system cases challenge traditional clinical tools because the answer lives at the intersection of specialties. Here is why these cases are hard, what an ideal tool would do, and what the evidence shows.
Drug-Nutrient Interactions Physicians Miss: A Cross-System Review
Your patient on metformin, furosemide, omeprazole, escitalopram, and atorvastatin faces simultaneous depletion of B12, magnesium, thiamine, calcium, sodium, and CoQ10. No EHR alert will fire for this pattern. Nobody owns it.
The Gut-Brain Axis: Clinical Evidence for Psychiatric Practice
The microbiome-mood connection is real and biologically plausible. But in 2026, the clinical implications are more modest than the headlines suggest: dietary counseling has good adjunctive evidence, specific probiotic strains show small effects, and GI comorbidity screening should be standard. Here is what the data actually support.
Cross-System Clinical Reasoning: Why No Single Specialty Has the Full Picture
Cross-system clinical reasoning connects evidence across organ systems and specialties to reveal diagnoses and treatment strategies that no single specialty perspective would identify. Here is why it matters, with detailed case examples.
Beyond Single-Specialty Answers: Why Cross-System Reasoning Matters
A 58-year-old with type 2 diabetes, eGFR 38, and new atrial fibrillation needs anticoagulation. The cardiology answer, the nephrology answer, and the endocrinology answer are three different answers. Your patient needs one.
Evidence-Based Medicine in the Age of Information Overload: A Physician's Survival Guide
With 1.5 million new medical articles published annually, staying current with evidence-based medicine is impossible through traditional methods. A practical guide for managing medical information overload without compromising patient care.
Patient-Specific Evidence: Why Subgroup Data Changes Clinical Decisions
Overall trial results often mask clinically important differences between patient subgroups. Understanding when and how subgroup data changes the decision is essential for truly personalized evidence-based medicine.
Shared Decision-Making with Complex Evidence: A Practical Guide
Shared decision-making works best when the evidence is clear. It matters most when the evidence is not. Here is a framework for communicating NNT, NNH, uncertainty, and conflicting data to patients who need to make real decisions.
When Depression Doesn't Respond to SSRIs: A Cross-System Differential
Before you add an atypical antipsychotic to that SSRI, check the thyroid, the B12, the CRP, and the sleep study. A structured cross-system evaluation reveals treatable causes in up to 40% of cases labeled treatment-resistant.
What to Look for in a Clinical Decision Support Tool in 2026
Five years ago, clinical decision support meant UpToDate. The landscape in 2026 looks different. Here is a framework for evaluating tools based on what actually matters when you are standing in front of a patient.
SGLT2 Inhibitors in HFpEF with CKD: What the Evidence Shows
A 72-year-old with HFpEF, eGFR 34, type 2 diabetes, and a recent heart failure hospitalization. Should she start an SGLT2 inhibitor? The answer spans three trial programs, and the data are clearer than you might expect.
The Bench-to-Bedside Gap: Why Evidence Takes 17 Years to Reach Patients
SGLT2 inhibitors have a Class I recommendation for heart failure. Only 13% of eligible patients are on one. The gap between what the evidence shows and what patients receive is measured in decades and tens of thousands of lives. Here is where the years go.